U.S. Anti-Drug Operations Intensify in Caribbean and Pacific, Leading to Fatal Strikes and Expanded Scope
The U.S. has intensified anti-drug operations in the Caribbean and Pacific, conducting strikes that resulted in nearly 40 deaths. President Trump plans to expand this crackdown to target cartel members within countries like Venezuela.

‘We’re just gonna kill people’: Trump says he does not need declaration of war for Venezuela strikes – live

Trump indicates he won't seek congressional approval for targeting drug traffickers

Trump says land targets 'next' in Pentagon drug trafficking crackdown
Trump insists he can strike alleged drug traffickers without Congress declaring war | Politics
Overview
Since early September, the U.S. has conducted multiple military strikes on suspected drug vessels across the Caribbean and Pacific, aiming to disrupt major international drug trafficking networks.
These intensified operations have reportedly led to nearly 40 fatalities, though two alleged drug traffickers were confirmed to have survived a recent U.S. military strike in the Caribbean.
Following these incidents, individuals from Colombia and Ecuador were successfully rescued by U.S. forces and subsequently repatriated to their respective home countries via a U.S. Navy warship.
Amidst these anti-drug efforts, President Trump denied reports of U.S. B-1 bombers flying near Venezuela, a claim that has contributed to escalating regional tensions.
President Trump intends to significantly broaden his administration's drug trade crackdown, shifting focus from international waters to directly targeting cartel members within nations like Venezuela.
Analysis
Center-leaning sources cover this story neutrally, presenting a balanced account of President Trump's controversial remarks on targeting drug traffickers without congressional approval. They include direct quotes from the administration, report on congressional concerns, and incorporate international criticism, allowing readers to form their own conclusions without editorial bias.